2 completed, 1 enrolling by invitation, 1 withdrawn. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Enrolling by invitation 1, Withdrawn 1 |
Follow PAH: new trials by email Literature Review of PAH trials Research Report on PAH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TSPO Endothelial - EMPATHY XBD173 - PAH | Phase 1 | Enrolling by invitation | Imperial College London | 6 | 2026-05-13 | 2026-07-13 |
| Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg Macitentan and Tadalafil film-coated tablets, PrOpsynvi® macitentan and tadalafil film-coated tablets - PAH | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 30 | 2024-05-14 | 2024-08-14 |
| Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg Macitentan and Tadalafil, PrOpsynvi® Film-Coated Tablets - PAH | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 30 | 2024-05-10 | 2024-09-19 |
| Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers TransCon PEG treprostinil - PAH | Phase 1 | Withdrawn | United Therapeutics | 2014-07-01 | 2014-08-07 |
macitentan (2) · N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide (1) · Tadalafil (1)
Humanis Saglık Anonim Sirketi (2) · Imperial College London (1) · United Therapeutics (1)
India (2) · United Kingdom (1) · United States (1)
Martin Wilkins (1)